SCHEMBL29616793

SCHEMBL29616793

C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)[C@@H](C)O

nearest known ligand 0.52

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ RAMP3 O60896 6/20 0.49
▸ CALCR P30988 6/20 0.49
▸ OPRM1 P35372 6/20 0.48
▸ OPRK1 P41145 6/20 0.48
▸ CXCR4 P61073 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29380215 0.90 RAMP3 (0.53) RAMP3CALCRCXCR4
SCHEMBL30175378 0.89 RAMP3 (0.56) RAMP3CALCRCXCR4
SCHEMBL31188444 0.88 NRP1 (0.48) RAMP3CALCROPRM1OPRK1
SCHEMBL30261962 0.87 RAMP3 (0.52) RAMP3CALCR
SCHEMBL5057725 0.86 CXCR4 (0.45) OPRM1OPRK1CXCR4
SCHEMBL29906304 0.86 OPRM1 (0.47) RAMP3CALCROPRM1OPRK1CXCR4
SCHEMBL29380657 0.85 OPRM1 (0.53) RAMP3CALCROPRM1OPRK1CXCR4
SCHEMBL29680195 0.85 RAMP3 (0.52) RAMP3CALCRCXCR4
SCHEMBL30974402 0.85 NPY2R (0.55) RAMP3CALCROPRM1OPRK1
SCHEMBL30988895 0.85 RAMP3 (0.53) RAMP3CALCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250367300-A1 Nanomaterial and Methods of Use Thereof UNIVERSITY OF CONNECTICUT (US) 2025-12-04 — — US disclosed
US-20250302762-A1 NANOMATERIAL DELIVERY VEHICLE AND METHOD OF USE THEREOF UNIVERSITY OF CONNECTICUT (US) 2025-10-02 — — US disclosed
US-20250302971-A1 Therapeutic Nanomaterials UNIV CONNECTICUT (US) 2025-10-02 — — US disclosed
US-12214043-B2 Therapeutic nanomaterials UNIVERSITY OF CONNECTICUT 2025-02-04 — — US disclosed
US-20220133893-A1 Therapeutic Nanomaterials UNIVERSITY OF CONNECTICUT 2022-05-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250302971-A1 Therapeutic Nanomaterials TIE1, TEKT1, POLRMT RAMP3 4232/4885CALCR 2464/4885OPRM1 4301/4885
US-20220133893-A1 Therapeutic Nanomaterials TIE1, TEKT1, POLRMT RAMP3 4232/4885CALCR 2464/4885OPRM1 4301/4885
US-20250367300-A1 Nanomaterial and Methods of Use Thereof EPCAM, CD47, JAK2 RAMP3 4144/4885CALCR 3553/4885OPRM1 2567/4885
US-20250302762-A1 NANOMATERIAL DELIVERY VEHICLE AND METHOD OF USE THEREOF JAK2, JAK1, CHMP4B RAMP3 4437/4885CALCR 2879/4885OPRM1 1681/4885
US-12214043-B2 Therapeutic nanomaterials TIE1, TEKT1, POLRMT RAMP3 4232/4885CALCR 2464/4885OPRM1 4301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback